Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Warner Chilcott Stock Hits New 52-Week Low
TheStreet.com
Thursday, December 13, 2012 - 4:24pm
tags:
Warner Chilcott
Synta Pharma: Poised For A Breakout With 4 Near-Term Catalysts
Seeking Alpha
Thursday, December 13, 2012 - 4:23pm
tags:
Synta Pharmaceuticals, Ariad Pharma, GSK, Bristol-Myers Squibb
3 Keys From Avanir's Quarterly Results
Motley Fool
Thursday, December 13, 2012 - 4:22pm
tags:
Avanir, earnings
'Trouble Is Opportunity' - Endo Fallout Is Worth A Look
Seeking Alpha
Thursday, December 13, 2012 - 11:55am
tags:
Endo Health Solutions
Avastin Shows No Benefit for Earlier Colon Cancer: Study
Medine Plus
Thursday, December 13, 2012 - 11:52am
tags:
Avastin, colon cancer, Roche
Cerapedics raises $19M in Series C round
Mass Device
Thursday, December 13, 2012 - 11:50am
tags:
Cerapedics, Series C
Masimo debuts 1st iPhone pulse oximeter
Mass Device
Thursday, December 13, 2012 - 11:49am
tags:
Masimo, pulse oximetry
Lilly stops rheumatoid arthritis trial for lack of efficacy
Reuters
Thursday, December 13, 2012 - 11:38am
tags:
Eli Lilly, tabalumab, rheumatoid arthritis
Pharmacyclics And Promising Advances In Leukemia Treatment
Seeking Alpha
Thursday, December 13, 2012 - 11:36am
tags:
Pharmacyclics, chronic lymphocytic leukemia, ibrutinib
Buy These 3 Cancer Stocks With Upcoming Catalysts
Seeking Alpha
Thursday, December 13, 2012 - 11:34am
tags:
Celsion, Dendreon, Threshold Pharmaceuticals
2 Biotech Stocks To Consider This Week In The Wake Of Trial Data
Seeking Alpha
Thursday, December 13, 2012 - 11:33am
tags:
Celldex, Alnylam, rindopepimut, ALN-TTR02, RNAi
Dendreon's Roller Coaster Still Rocking
Motley Fool
Thursday, December 13, 2012 - 11:31am
tags:
Dendreon
KV says it is set to emerge from bankruptcy
Fierce Pharma
Thursday, December 13, 2012 - 11:31am
tags:
KV Pharmaceutical
Pharma M&A takes nosedive, except in China
Fierce Pharma
Thursday, December 13, 2012 - 11:27am
tags:
M&A, China
Pfizer Pays $43M For Off-Label Promotion, Again
Pharmalot
Thursday, December 13, 2012 - 11:26am
tags:
Pfizer, off-label, Zyvox, Lyrica
FDA Says Chantix May Cause Heart Risks
Pharmalot
Thursday, December 13, 2012 - 11:24am
tags:
Chantix, FDA, smoking cessation, Pfizer
Lundbeck gets U.S. nod for antidepressant submission
Reuters
Thursday, December 13, 2012 - 11:23am
tags:
antidepressants, Lundbeck, vortioxetine, Lexapro
Merck CEO warns price controls could hamper drug innovation, FT says
Yahoo/Fly on the Wall
Thursday, December 13, 2012 - 11:06am
tags:
innovation, Merck, Pharma CEOs, Kenneth Frazier
Hopes fade for AstraZeneca and Rigel's arthritis pill
Reuters
Thursday, December 13, 2012 - 11:05am
tags:
Rigel, AstraZeneca, fostamatinib, Humira, Abbott Labs, rheumatoid arthritis
1 Small Pharma Proving That Partnerships Pay
Motley Fool
Thursday, December 13, 2012 - 11:04am
tags:
Isis Pharmaceuticals, Biogen Idec

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.